| | DECEMBER 202119UTLOOKHealthcare Tech Within the ActivEdge surgical intelligence platform is the ActivSightTM interoperable imaging module, which received 510(k) clearance from the Food and Drug Administration in April 2021. This technology is designed to integrate with already-installed hospital visualization systems to deliver instantaneous, intra-operative visual data and images previously invisible to surgeons, such as real-time perfusion data. The ActivSight imaging module serves as the "eyes" of the ActivEdge platform. It powers visualization software to allow surgeons to see blood flow in real time, including the company's initial commercial offering: the ActivInsights software suite.The ActivInsightsTM software suite is a proprietary augmented reality (AR)-based bundle that offers real-time tissue assessment in the form of previously unavailable visual overlays. The ActivInsights enhanced visualization software will provide a visual map of the surgical area, making previously invisible and critical structures visible to surgeons cost-effectively and in real-time. In the coming years, as adoption of Activ Surgical's technology grows, the potential exists for the additional incorporation of AI- and ML-derived information from tens of thousands of surgical data points to be analyzed and fed into the cloud, which would then allow physicians to identify key anatomical structures during surgeries. Potential capabilities include geofence capabilities to protect critical organs, nerves, arteries, and veins during surgery. To date, 13 major healthcare systems around the world have committed to pilots of the technology. Activ Surgical expects the ActivInsights software to be commercially available to surgeons around the world in 2022 via a technology-as-a-service (TaaS) pricing model that will include the ActivSight intraoperative hardware. Activ Surgical's ability to provide actionable, real-time perfusion data to surgeons is game-changing when considering over 50 million procedures--from minimally invasive surgeries to laparoscopic and arthroscopic surgeries--require precise perfusion data to avoid lethal complications, such as anastomotic leaks which are one of the most common and costly complications. "Today, there are no mechanisms that allow physicians to identify blood flow rates after they sew up an anastomosis. Our solutions focus on 11.2 million of the most common surgical procedures and ensure that surgeons have the necessary perfusion data to avoid complications," Usen explains. With a highly skilled leadership team possessing a collective medtech experience spanning more than 160 years, Activ Surgical has stayed the course of innovation for over four years. The company's FDA-cleared technology has paved the way for even healthcare facilities with low capital budgets to seamlessly adapt to their existing scopes and imaging equipment. Once the ActivSight enhanced visualization system is implemented into surgical devices across hundreds of healthcare facilities, the plan is for surgeons to leverage the data aggregated by the AI to better identify nerves, arteries, and other critical structures. Akin to how a smartwatch or a phone may collect data to curate a specific user experience, the ActivSight visualization system plans to collate data from its various surgical applications to expedite the growth of healthcare technology. "We believe we've covered the last mile in AI-powered surgical technology," concludes Usen. HT
< Page 9 | Page 11 >